Literature DB >> 18594026

A 50-year-old woman addicted to heroin: review of treatment of heroin addiction.

Charles P O'Brien1.   

Abstract

Heroin addiction is a complicated medical and psychiatric issue, with well-established as well as newer modes of treatment. The case of Ms W, a 50-year-old woman with a long history of opiate addiction who has been treated successfully with methadone for 9 years and who now would like to consider newer alternatives, illustrates the complex issues of heroin addiction. The treatment of heroin addiction as a chronic disease is reviewed, including social, medical, and cultural issues and pharmacologic treatment with methadone and the more experimental medication options of buprenorphine and naltrexone.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18594026      PMCID： PMC3812920          DOI： 10.1001/jama.300.1.jrr80005

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


  40 in total

1.  Opium, cocaine and marijuana in American history.

Authors:  D F Musto
Journal:  Sci Am       Date:  1991-07       Impact factor: 2.142

2.  A controlled trial of buprenorphine treatment for opioid dependence.

Authors:  R E Johnson; J H Jaffe; P J Fudala
Journal:  JAMA       Date:  1992-05-27       Impact factor: 56.272

3.  Three therapeutic communities. A prospective controlled study of narcotic addiction treatment: process and two-year follow-up results.

Authors:  R N Bale; V P Zarcone; W W Van Stone; J M Kuldau; T M Engelsing; R M Elashoff
Journal:  Arch Gen Psychiatry       Date:  1984-02

4.  Modern treatment of substance abuse.

Authors:  C P O'Brien; G E Woody; A T McLellan
Journal:  Drug Alcohol Depend       Date:  1983-02       Impact factor: 4.492

5.  Therapeutic communities vs methadone maintenance. A prospective controlled study of narcotic addiction treatment: design and one-year follow-up.

Authors:  R N Bale; W W Van Stone; J M Kuldau; T M Engelsing; R M Elashoff; V P Zarcone
Journal:  Arch Gen Psychiatry       Date:  1980-02

6.  Naltrexone pharmacotherapy for opioid dependent federal probationers.

Authors:  J W Cornish; D Metzger; G E Woody; D Wilson; A T McLellan; B Vandergrift; C P O'Brien
Journal:  J Subst Abuse Treat       Date:  1997 Nov-Dec

7.  Performance differences between addicts and non-addicts.

Authors:  S Rothenberg; S Schottenfeld; R E Meyer; B Krauss; K Gross
Journal:  Psychopharmacology (Berl)       Date:  1977-05-09       Impact factor: 4.530

8.  High-risk behaviors for HIV: a comparison between crack-abusing and opioid-abusing African-American women.

Authors:  E Cohen; H Navaline; D Metzger
Journal:  J Psychoactive Drugs       Date:  1994 Jul-Sep

9.  Naltrexone treatment of heroin addiction: one-year follow-up.

Authors:  B A Judson; A Goldstein
Journal:  Drug Alcohol Depend       Date:  1984-07       Impact factor: 4.492

Review 10.  Developmental outcome of children born to methadone maintained women: a review of longitudinal studies.

Authors:  K Kaltenbach; L P Finnegan
Journal:  Neurobehav Toxicol Teratol       Date:  1984 Jul-Aug
View more
  7 in total

1.  Where Is Buprenorphine Dispensed to Treat Opioid Use Disorders? The Role of Private Offices, Opioid Treatment Programs, and Substance Abuse Treatment Facilities in Urban and Rural Counties.

Authors:  Bradley D Stein; Rosalie Liccardo Pacula; Adam J Gordon; Rachel M Burns; Douglas L Leslie; Mark J Sorbero; Sebastian Bauhoff; Todd W Mandell; Andrew W Dick
Journal:  Milbank Q       Date:  2015-09       Impact factor: 4.911

2.  Growth In Buprenorphine Waivers For Physicians Increased Potential Access To Opioid Agonist Treatment, 2002-11.

Authors:  Andrew W Dick; Rosalie L Pacula; Adam J Gordon; Mark Sorbero; Rachel M Burns; Douglas Leslie; Bradley D Stein
Journal:  Health Aff (Millwood)       Date:  2015-06       Impact factor: 6.301

3.  A randomized trial of oral naltrexone for treating opioid-dependent offenders.

Authors:  Donna M Coviello; James W Cornish; Kevin G Lynch; Arthur I Alterman; Charles P O'Brien
Journal:  Am J Addict       Date:  2010 Sep-Oct

Review 4.  Potential uses of naltrexone in emergency department patients with opioid use disorder.

Authors:  Evan Stuart Bradley; David Liss; Stephanie Pepper Carreiro; David Eric Brush; Kavita Babu
Journal:  Clin Toxicol (Phila)       Date:  2019-03-04       Impact factor: 4.467

5.  Obstructive sleep apnea is more common than central sleep apnea in methadone maintenance patients with subjective sleep complaints.

Authors:  Katherine M Sharkey; Megan E Kurth; Bradley J Anderson; Richard P Corso; Richard P Millman; Michael D Stein
Journal:  Drug Alcohol Depend       Date:  2010-01-15       Impact factor: 4.492

6.  Policies related to opioid agonist therapy for opioid use disorders: The evolution of state policies from 2004 to 2013.

Authors:  Rachel M Burns; Rosalie L Pacula; Sebastian Bauhoff; Adam J Gordon; Hollie Hendrikson; Douglas L Leslie; Bradley D Stein
Journal:  Subst Abus       Date:  2015-11-13       Impact factor: 3.716

7.  A population-based examination of trends and disparities in medication treatment for opioid use disorders among Medicaid enrollees.

Authors:  Bradley D Stein; Andrew W Dick; Mark Sorbero; Adam J Gordon; Rachel M Burns; Douglas L Leslie; Rosalie Liccardo Pacula
Journal:  Subst Abus       Date:  2018-06-22       Impact factor: 3.716
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.